Publications

  1. Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Loss-of-function of the Voltage-gated Sodium Channel NaV1.5 (Channelopathies) in Patients with Irritable Bowel Syndrome. Gastroenterology. 2014 Mar 05.
    View PubMed
  2. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012 Oct; 57(10):2650-7. Epub 2012 Aug 02.
    View PubMed
  3. Hellstrom PM, Saito YA, Bytzer P, Tack J, Mueller-Lissner S, Chang L. Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria. Am J Gastroenterol. 2011 Jul; 106(7):1299-307. Epub 2011 Mar 29.
    View PubMed
  4. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 May; 33(9):1059-67. Epub 2011 Mar 13.
    View PubMed
  5. Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am. 2011 Mar; 40(1):45-67.
    View PubMed
  6. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR 3rd, Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr; 105(4):833-41. Epub 2010 Mar 16.
    View PubMed
  7. Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology. 2010 Apr; 138(4):1276-85. Epub 2010 Feb 19.
    View PubMed
  8. Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol. 2010 Jan; 105(1):170-7. Epub 2009 Oct 06.
    View PubMed
  9. Saito YA, Talley NJ. AJG series: molecular biology for clinicians. Am J Gastroenterol. 2009 Oct; 104(10):2583-7. Epub 2009 Jun 23.
    View PubMed
  10. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296(2):G211-8. Epub 2008 Dec 04.
    View PubMed
  11. Saito YA. Genes and irritable bowel syndrome: is there a link? Curr Gastroenterol Rep. 2008 Aug; 10(4):355-62.
    View PubMed
  12. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008 Aug; 103(8):2100-4; quiz 2105. Epub 2008 Jul 05.
    View PubMed
  13. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008 Jul; 20(7):790-7.
    View PubMed
  14. Camilleri M, Saito YA. Pharmacogenomics in gastrointestinal disorders. Methods Mol Biol. 2008; 448:395-412.
    View PubMed
  15. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jun; 19(6):465-70.
    View PubMed
  16. Saito YA, Camilleri M. Clinical application of pharmacogenetics in gastrointestinal diseases. Expert Opin Pharmacother. 2006 Oct; 7(14):1857-69.
    View PubMed
  17. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
    View PubMed
  18. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol. 2006 Jun; 101(6):1379-89.
    View PubMed
  19. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: A population-based case-control study. Am J Gastroenterol. 2005 Dec; 100(12):2743-8.
    View PubMed
  20. Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1057-65.
    View PubMed
  21. Saito YA, Prather CM, Van Dyke CT, Fett S, Zinsmeister AR, Locke GR III. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004 Jul; 2(7):576-84.
    View PubMed
  22. Saito YA, Fox JC. Management of functional abdominal pain. Curr Treat Options Gastroenterol. 2004; 7(4):279-90.
    View PubMed
  23. Saito YA, Talley NJ, Melton LJ, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 Dec; 15(6):687-94.
    View PubMed
  24. Saito YA, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: A systematic review. Am J Gastroenterol. 2002 Aug; 97(8):1910-5.
    View PubMed
  25. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol. 2002 Apr; 33(4):435-6.
    View PubMed
  26. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000 Oct; 95(10):2816-24.
    View PubMed